<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101465726</journal-id>
<journal-id journal-id-type="pubmed-jr-id">35618</journal-id>
<journal-id journal-id-type="nlm-ta">Brain Stimul</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain Stimul</journal-id>
<journal-title-group>
<journal-title>Brain stimulation</journal-title>
</journal-title-group>
<issn pub-type="ppub">1935-861X</issn>
<issn pub-type="epub">1876-4754</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30337243</article-id>
<article-id pub-id-type="pmc">6301148</article-id>
<article-id pub-id-type="doi">10.1016/j.brs.2018.10.005</article-id>
<article-id pub-id-type="manuscript">NIHMS1509143</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Modulation of Neuroinflammation and Memory Dysfunction using
Percutaneous Vagus Nerve Stimulation in Mice.</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Huffman</surname>
<given-names>William J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Subramaniyan</surname>
<given-names>Saraswathi</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rodriguiz</surname>
<given-names>Ramona M.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wetsel</surname>
<given-names>William C.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grill</surname>
<given-names>Warren M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Terrando</surname>
<given-names>Niccolò</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Biomedical Engineering, Duke University,
Durham, North Carolina 27708, USA</aff>
<aff id="A2"><label>2</label>Center for Translational Pain Medicine, Department of
Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710,
USA</aff>
<aff id="A3"><label>3</label>Department of Psychiatry and Behavioral Sciences, Mouse
Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical
Center, Durham, North Carolina 27710, USA</aff>
<aff id="A4"><label>4</label>Departments of Neurobiology and Cell Biology, Duke
University Medical Center, Durham, NC 27710 USA</aff>
<aff id="A5"><label>5</label>Departments of Electrical and Computer Engineering,
Neurobiology, and Neurosurgery, Duke University, Durham, North Carolina 27708,
USA</aff>
<author-notes>
<fn fn-type="other" id="FN1">
<label>*</label>
<p id="P68">shared contribution</p>
</fn>
<corresp id="CR2">Correspondence: Niccolò Terrando, BSc (hons), DIC, PhD,
Center for Translational Pain Medicine, Department of Anesthesiology, Duke
University Medical Center; Tel: +1-919-684-6121;,
<email>niccolo.terrando@duke.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P41">Conflicts of interest</p>
<p id="P42">None.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>8</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<season>Jan-Feb</season>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>12</volume>
<issue>1</issue>
<fpage>19</fpage>
<lpage>29</lpage>
<!--elocation-id from pubmed: 10.1016/j.brs.2018.10.005-->
<abstract id="ABS1">
<sec id="S1">
<title>Background:</title>
<p id="P1">The vagus nerve is involved in regulating immunity and resolving
inflammation. Current strategies aimed at modulating neuroinflammation and
cognitive decline, in many cases, are limited and ineffective.</p>
</sec>
<sec id="S2">
<title>Objective:</title>
<p id="P2">We sought to develop a minimally invasive, targeted, vagus nerve
stimulation approach (pVNS), and we tested its efficacy with respect to
microglial activation and amelioration of cognitive dysfunction following
lipopolysaccharide (LPS) endotoxemia in mice.</p>
</sec>
<sec id="S3">
<title>Methods:</title>
<p id="P3">We stimulated the cervical vagus nerve in mice using an
ultrasound-guided needle electrode under sevoflurane anesthesia. The
concentric bipolar needle electrode was percutaneously placed adjacent to
the carotid sheath and stimulation was verified in real-time using
bradycardia as a biomarker. Activation of vagal fibers was confirmed with
immunostaining in relevant brainstem structures, including the dorsal motor
nucleus and nucleus tractus solitarius. Efficacy of pVNS was evaluated
following administration of LPS and analyses of changes in inflammation and
behavior.</p>
</sec>
<sec id="S4">
<title>Results:</title>
<p id="P4">pVNS enabled stimulation of the vagus nerve as demonstrated by
changes in bradycardia and histological evaluation of c-Fos and choline
acetyltransferase expression in brainstem nuclei. Following LPS
administration, pVNS significantly reduced plasma levels of tumor necrosis
factor-α at 3 h post-injection. pVNS prevented LPS-induced
hippocampal microglial activation as analyzed by changes in Iba-1
immunoreactivity, including cell body enlargement and shortened
ramifications. Cognitive dysfunction following endotoxemia was also restored
by pVNS.</p>
</sec>
<sec id="S5">
<title>Conclusion:</title>
<p id="P5">Targeted cervical VNS using this novel percutaneous approach reduced
LPS-induced systemic and brain inflammation and significantly improved
cognitive responses. These results provide a novel therapeutic approach
using bioelectronic medicine to modulate neuro-immune interactions that
affect cognition.</p>
</sec>
</abstract>
<kwd-group>
<kwd>cognition</kwd>
<kwd>cytokines</kwd>
<kwd>microglia</kwd>
<kwd>neuroinflammation</kwd>
<kwd>percutaneous</kwd>
<kwd>vagus nerve stimulation</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>